SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-018494
Filing Date
2024-05-09
Accepted
2024-05-09 17:00:38
Documents
5
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 397565
2 formdef_001.jpg GRAPHIC 4937
3 proxy_003.jpg GRAPHIC 265727
4 proxy_004.jpg GRAPHIC 351352
5 proxy_005.jpg GRAPHIC 210584
  Complete submission text file 0001493152-24-018494.txt   1545947
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40789 | Film No.: 24931698
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)